Key words: anti-inflammatory drugs; CD11/CD18 inte-and are putative endogenous inhibitors of inflammation [18][19][20][21][22]. Here we review briefly the major biosyngrins; eicosanoids; endothelium; glomerulonephritis; leukocyte adhesion; leukocytes; leukotrienes; lipoxins; thetic pathways for leukotriene and lipoxin synthesis in vitro and in vivo, we summarize their bioactions with P-selectin; transcellular metabolism specific reference to glomerulonephritis, and we discuss the therapeutic opportunities spawned by recent advances in this field.
Introduction

Biosynthesis and metabolism of leukotrienes and
Glomerulonephritis is a leading cause of end-stage lipoxins renal failure worldwide. The therapeutic options for LT biosynthesis and metabolism. LT are generated by patients with immune-mediated glomerular diseases several different cell types from endogenous arachidonhave changed little in recent times, and consist mainly ate or from arachidonate intermediates derived from of broad spectrum immunosuppressive regimens involneighbouring cells during cell-cell interactions [1-6; ving corticosteroids, azathioprine, cyclophosphamide, Figure 1 ]. LT biosynthesis is initiated, in part, by and cyclosporine. The pressing need for more effective increments in cytosolic calcium concentration triggered and less toxic therapies has focused attention on the by receptor activation or physical stimuli (e.g. trauma, diverse mediators that regulate the initiation, ampliburns) [1] [2] [3] [4] [5] [6] 23] . Increased cytosolic calcium levels fication, maintenance, and resolution phases of glomerstimulate translocation of the cytosolic enzyme phosular inflammation. Amongst these mediators, the pholipase A 2 to cell membranes where it cleaves arachileukotrienes and lipoxins are particularly intriguing as donic acid from membrane-bound phospholipid [23] . they appear to play counter-regulatory roles within
The major bioactive LTB 4 , and the sulfidopeptide inflamed glomeruli that influence leukocyte recruitleukotrienes, LTC 4 , LTD 4 , and LTE 4 , are derived from ment, vascular tone and other pivotal pathophysioa common precursor, LTA 4 [1-6 ]. The latter is generlogical events [1] [2] [3] [4] [5] [6] .
ated by the insertion of molecular oxygen and abstracLeukotrienes (LT ) and lipoxins are eicosanoids, i.e.
tion of hydrogen at carbon-5 of arachidonic acid, a 20-carbon derivatives of membrane-derived arachireaction catalyzed by 5-lipoxygenase when associated donic acid, that are generated via biochemical pathwith 5-lipoxygenase activating protein ( FLAP) [24, 25] . ways catalyzed by lipoxygenase enzymes [1] [2] [3] [4] [5] [6] . They 5-Lipoxygenase expression appears to be limited to are components of the pleiotropic 'arachidonic acid leukocytes, with the exception of colon cancer cells cascade', which include prostaglandins, prostacyclins, and some cell lines [1] [2] [3] [4] [5] [6] . LTB 4 is generated from and thromboxanes, among other lipid mediators [1] [2] [3] [4] [5] [6] .
LTA 4 by net addition of water, a reaction catalyzed LT are potent pro-inflammatory compounds and have by LTA 4 hydrolase. Omega-oxidation of LTB 4 to been detected in serum, urine and renal tissue during 20-OH-LTB 4 and 20-COOH-LTB 4 through a P 450 glomerular inflammation [7] [8] [9] [10] [11] [12] . In this setting, they enzymatic system represents the major pathway for have been implicated as triggers for neutrophil recruit-LTB 4 degradation in mammalian cells and is generally ment and activation, intrarenal vasoconstriction, mesassociated with loss of biological activity [1, 6 ] . angial cell contraction, and proliferation of resident Interestingly, LTB 4 is an activating ligand for the glomerular cells [13] [14] [15] [16] [17] [18] [19] [20] . Lipoxins antagonize many transcription factor peroxisome proliferator-activated responses evoked by LT (and indeed other mediators), receptor-a (PPARa). Activated PPARa upregulates expression of enzymes that oxidatively degrade fatty Correspondence and offprint requests to: Professor Hugh R Brady, acids and their derivatives, including LTB 4 , suggesting Department of Medicine and Therapeutics, Mater Misericordiae the presence of a feedback loop that may limit the transcellular leukotriene formation is postulated to be a major source of leukotrienes during glomerular inflammation in vivo [26 ] .
Leukocyte adhesion to vascular endothelium and other glomerular cells is a key event in leukocyte recruitment during glomerular inflammation and promotes other pro-inflammatory activities such as free radical generation and degranulation, cytotoxicity and antigen presentation [35, 36 ] . Interestingly, these adhesive events also promote transcellular leukotriene biosynthesis during interaction between neutrophils and glomerular endothelial cells in vitro [33; Figure 2] . Potential mechanisms by which eicosanoid production is augmented in this setting include approximation of cell membranes, thereby facilitating transfer of lipophilic arachidonate intermediates between lipid bilayers, and priming of neutrophil lipoxygenase pathways through cell signalling events activated by engagement of adhesion molecules (so-called 'outside-in' cell signalling through adhesion molecules) [22] . Given that leukotrienes are themselves potent stimuli for leukocyte-endothelial cell adhesion (vide infra), these observations suggest the presence of complex leukotriene-adhesion networks that, if allowed to proceed unchecked, would ultimately amplify leukocyte recruitment and tissue injury. Thy-1 nephritis, nephrotoxic serum nephritis and glomerular injury induced by cationic bovine gamma globulin [7, 8, 10, [37] [38] [39] [40] [41] . The detection and measure- [25] . Sulfidopeptide leukotrienes are formed by the addition of glutathione to carbon-6 of LTA 4 to form ment of the peptidoleukotrienes in glomerular isolates has been hampered by methodological constraints; LTC 4 , a reaction catalyzed by LTC 4 synthase/glutathione-S-transferase [1, 5, 6 ] . The sequential removal of nevertheless, peptidoleukotrienes have been detected in experimental immune complex glomerulonephritis glutamic acid and glycine residues by specific dipeptidases yields LTD 4 and LTE 4 , respectively. In general, in rats, in mice with spontaneous lupus nephritis, and in human glomerulonephritis [9, 42] . The relative con-LTC 4
and LTD 4 are bioactive, and metabolism of LTD 4 to LTE 4 is associated with loss of biological tributions of leukocyte-restricted and transcellular pathways to leukotriene biosynthesis during glomeractivity.
Whereas relatively homogenous populations of leu-ular inflammation is still being defined. Prior depletion of neutrophils in animals markedly reduces LTB 4 levels kocytes generate leukotrienes in abundance when activated in vitro (e.g. eosinophils, basophils, mast cells), and inflammatory injury in experimental glomerulonephritis confirming that leukocytes are the major transcellular biosynthetic pathways are being increasingly recognized as important routes for amplification sources of LTA 4 in this setting [41] . In vitro assessment of transcellular leukotriene formation during interof the quantities and profile of lipoxygenase-derived eicosanoids within a multicellular inflammatory milieu actions of cytokine-primed neutrophils and glomerular endothelial cells suggests that transcellular routes play [26 ] The 'anti-inflammatory' potential of the lipoxins has been underscored by exciting reports that aspirin 15-and 5-lipoxygenase to yield an unstable epoxide intermediate, 5,6-epoxytetraene [1,4] . The latter is con-triggers production of lipoxin epimers during coincubations of neutrophils and endothelial cells in verted to the major bioactive lipoxins LXA 4 and LXB 4 via reactions catalyzed by epoxide hydrolases [1, 4] . vitro [53,54; Figure 2 ]. In the presence of aspirin, prostaglandin production by cycloxygenase-2 (COX-2) Lipoxin biosynthesis is greatly augmented, however, through transcellular pathways if granulocytes are is inhibited; however, aspirin-acetylated COX-2 retains the ability to convert arachidonic acid to 15(R)-HETE. activated during co-incubation with platelets [44] [45] [46] [47] [48] [49] [50] . Platelets cannot generate lipoxins from arachidonic The latter compound has anti-inflammatory potential by virtue of its ability to inhibit neutrophil-endothelial acid. During cell-cell interactions, however, platelets convert neutrophil-derived LTA 4 to 5,6-epoxytetraene cell adhesion [55, 56 ] . During cell-cell interactions, some endothelial-derived 15(R)-HETE is converted by through the action of platelet 12-lipoxygenase [44] [45] [46] [47] [48] [49] [50] . Within this framework, the term '12-lipoxygenase' is a neutrophil 5-lipoxygenase to either 15-epi-LXA 4 or 15-epi-LXB 4 which have anti-inflammatory properties misnomer as it refers to the enzyme's enzymatic activity with arachidonic acid. The same enzyme functions as similar to native lipoxins [53, 54] . Given that cytokines induce COX-2 expression at sites of inflammation, it a 15-lipoxygenase (LX synthase) when its substrate is LTA 4
[44-50]. Thus, within a multicellular inflam-is intriguing that aspirin, the prototype non-steroidal anti-inflammatory drug, diverts arachidonate metabolmatory environment, LTA 4 can serve as a key intermediate for both leukotriene and lipoxin formation. ism into production of a novel class of lipoxygenasederived eicosanoids that are potent inhibitors of As with peptidoleukotriene generation during interaction of neutrophils and glomerular endothelial cells, leukocyte-endothelial cell adhesion. These observations suggest a novel mechanism by which aspirin may leukocyte adhesion promotes transcellular lipoxin generation during platelet-neutrophil interaction [39,50,51; 
exert its anti-inflammatory effects in vivo.
Lipoxin generation has been demonstrated in a Figure 2 ]. The cytokines interleukin-4 and interleukin-13 induce 15-lipoxygenase expression in some cells, variety of human diseases including asthma, sarcoidosis, psoriasis, pneumonia and post-coronary angioraising the possibility that resident tissue cells also plasty [3, 57, 58] . With regard to renal disease, lipoxin
The pathways for lipoxin degradation are still being appreciated. The major route in leukocytes involves biosynthesis has been demonstrated in experimental immune complex glomerulonephritis in rats and mice dehydrogenation of alcohols and reduction of double bonds through enzymatic pathways analogous to those [39, 50] is the preferred substrate for this P 450 pathway and it is unlikely to be a major Figures 2 and 3] . Depletion of animals of either neutrophils or platelets prior to induction of glom-contributor to lipoxin degradation. The metabolic fate of lipoxins in vivo has yet to be determined. Future erulonephritis attenuates lipoxin generation, suggesting involvement of both cell types in lipoxin generation research in this area should enhance our understanding of the mechanisms by which tissue levels are regulated [50] . Monoclonal antibodies directed against platelet P-selectin, that inhibit platelet-neutrophil adhesion and during inflammation, provide useful surrogate markers of lipoxin bioactivity, and possibly reveal novel strattranscellular lipoxin production during plateletneutrophil interactions in vitro, also attenuate the egies through which to manipulate tissue lipoxin levels for therapeutic gain. generation of lipoxin A 4 in vivo [50] . Studies of acute passive anti-GBM nephritis model in P-selectin 'knockout' mice support a role for adhesion-dependent Biological activities: regulators of leukocyte recruitment platelet-neutrophil interactions as a major source of and vascular tone in glomerulonephritis LXA 4 within the vascular lumen [39, 59] . The latter site would be strategically advantageous for inhibition Leukotriene bioactivities. LTB 4 is a potent stimulus for neutrophil activation and induces chemotaxis, adheof further neutrophil recruitment during inflammation (vide infra) [39] . The relative importance of non-sion to endothelial cells, some superoxide anion generation and degranulation, and release of IL-8 [1-6 ]. haematogenous cells in transcellular lipoxin generation in vivo is unclear, but a role is possible given that LTB 4 also increases endothelial permeability and adhesiveness for neutrophils [62, 63] . Specific to the conversion of neutrophil-derived intermediates by renal cells expressing 12-or 15-lipoxygenase activity has kidney, intrarenal administration of LTB 4 into healthy rats leads to mild vasorelaxation and natriuresis [11] . been described [82] . Fig. 3 . Neutrophil-endothelial cell and neutrophil-platelet adhesion during acute immune complex-mediated glomerulonephritis (concanavalin A-ferritin-induced glomerulonephritis). Representative electron micrograph in (A) shows a glomerular capillary loop from a nephritic animal with infiltrating polymorphonuclear neutrophils (PMN ) and platelets (P) in close contact and occluding the lumen. These adhesive interactions were observed in association with biochemical evidence of transcellular lipoxin biosynthesis during P-selectin-dependent adhesion of neutrophils and platelets. Prior exposure of neutrophils to LXA 4 attenuates their recruitment to inflamed glomeruli in this model, suggesting the presence of a negative feedback loop that inhibits further neutrophil infiltration and promotes resolution of glomerulonephritis. (B) micrograph of a control animal (CL, capillary lumen; US, urinary space; Ep, visceral epithelial cell; RBC, red blood cell; End, endothelial cell ). Reprinted with permission from A. Papayianni et al. [50] .
In vitro studies reveal that LTB 4 triggers adhesion of mediators in vitro, and are putative endogenous 'stop signals' that inhibit neutrophil recruitment and neutrophils and monocytes to glomerular endothelial and mesangial cells through adhesive events involving promote resolution of inflammation [2] [3] [4] . LXA 4 and LXB 4 attenuate LTB 4 -induced neutrophil chemoneutrophil CD11/CD18 b integrins [20, 32, 64] . Intrarenal infusion of LTB 4 in rats with nephrotoxic taxis, neutrophil-endothelial cell adhesion, and migration of neutrophils across endothelial monolayers serum nephritis markedly increases neutrophil infiltration and amplifies the corresponding fall in renal blood [2] [3] [4] 19, 72, 73] . LXA 4 also blunts basolateral-toluminal migration of neutrophils across epithelial cell flow and glomerular filtration rate (GFR) [11] .
The profile of biological activities triggered by sulfi-monolayers induced by the synthetic peptide chemoattractant N-formyl-L-methionine-L-leucine-L-phenyldopeptide leukotrienes differs from LTB 4 . Originally classified as the 'slow-reacting substance of anaphyl-alanine (fMLP) [74] , chemotaxis of eosinophils in response to fMLP and platelet-activating factor axis', LTC 4 and LTD 4 are potent stimuli for contraction of bronchial and vascular smooth muscle. Infusion [75] , and fMLP-triggered upregulation of neutrophil CD11/CD18 integrins [70] . With regard to peptidoof LTC 4 into the renal artery leads to a marked reduction in renal blood flow, glomerular ultrafiltration leukotrienes, LXA 4 and LXB 4 attenuate LTC 4 -and LTD 4 -triggered endothelial hyperadhesiveness for coefficient and GFR [15, 16, 18] . LTC 4 and LTD 4 contract mesangial cells in vitro, a response that presum-neutrophils, in part by inhibiting mobilization of P-selectin [19] . The latter lipoxin bioactivity may, in ably underpins the fall in the glomerular filtration coefficient (K f ) in vivo [13, 14] . LTC 4 and LTD 4 alter turn, be mediated through stimulation of endothelial cell prostacyclin production [19] . A recent report indivascular permeability and enhance endothelial adhesiveness for neutrophils by provoking synthesis of plate-cates that LXA 4 and stable analogues of LXA 4 attenuate interleukin-8 release by colonic cell lines activated let-activating factor and mobilization of P-selectin from Weibel-Palade bodies to the cell surface by TNFa, raising the possibility that lipoxins also modulate cytokine responses in some cell types [76 ] . [2, 5, 19, 65, 66 ] . Adhesion of phagocytes to glomerular endothelial and mesangial cells is also enhanced by
In keeping with in vitro assessments of neutrophil trafficking, LXA 4 inhibits LTB 4 -induced neutrophil sulfidopeptides [20] . Leukotriene C 4 induces proliferation of renal epithelial cells in vitro, and both LTC 4 adhesion, diapedesis, and vascular permeability changes in the hamster cheek pouch model of the and D 4 have been implicated as stimuli for mesangial cell proliferation in animal models of proliferative microcirculation in vivo [73] . With regard to glomerular disease, treatment of rat neutrophils with LXA 4 ex glomerulonephritis [8, 9, 67] .
Leukotrienes modulate diverse cellular activities vivo blunts their subsequent trafficking to inflamed glomeruli in the concanavalin A-ferritin model of through interaction with high affinity cell surface receptors. Receptor engagement triggers cell signalling immune complex glomerulonephritis [50] . Depressed LXA 4 biosynthesis is associated with exaggerated neuevents that include G-protein coupled activation of phospholipase C, generation of inositol triphosphate trophil infiltration in nephrotoxic serum nephritis in P-selectin knockout mice, and measures that restore and diacylglycerol, elevation of cytosolic calcium concentrations, activation of kinase activities and phos-lipoxin generation bring glomerular neutrophil counts in 'knockout' animals to levels comparable with wildphorylation of intracellular proteins [1] [2] [3] [4] [5] [6] . Cloning and characterization of the human leukocyte LTB 4 type animals [39] . With regard to vascular tone, LXA 4 is a vasodilator, opposes the vasoconstrictor properties receptor has been reported recently [68] . Interestingly, the human LTB 4 receptor shows little homology to of LTD 4 , and attenuates LTD 4 -triggered decrements in renal blood flow, glomerular K f and GFR [18] . prostanoid receptors and, like the previously described myeloid LXA 4 receptor (vide infra), is a member of These vasoactive properties of lipoxins appear to be mediated through production of vasodilatory prostathe chemokine receptor superfamily [68] [69] [70] . In addition to localization on the cell surface, some LTB 4 glandins and nitric oxide, and/or partial agonist activity at peptidoleukotriene receptors [18, 19, 77, 78] . receptors are expressed at the nuclear envelope, raising the possibility that LTB 4 plays intracellular roles such Finally, LXA 4 blunts bronchial smooth muscle contraction in vitro and in vivo [79, 80] . Together, these as regulation of gene transcription [68] . Smooth muscle cells, endothelial cells and a variety of other cell types observations suggest potential immunomodulatory roles for lipoxins during host defense, inflammation express high affinity binding sites for LTC 4 and LTD 4 ; however, receptors for these lipoxygenase products and hypersensitivity disorders.
The molecular basis for these lipoxin-evoked have yet to be characterized at the molecular level [6 ] . It is likely that multiple signalling pathways are evoked responses is still being appreciated. Neutrophils, monocytes and gastrointestinal epithelial cells express by sulfidopeptide leukotrienes given a recent report demonstrating two distinct pathways in human mono-high affinity binding sites for lipoxins [69, 70, 76 ] . Given the biological activities of lipoxins (see below), it is cytic leukaemia THP-1 cells, namely a pertussis toxinsensitive chemotactic response and a pertussis toxin-likely that endothelial cells and mesangial cells also express lipoxin receptors. Cloning of the cDNA for insensitive mitogen-activated protein kinase activation through protein kinase Ca [71] . the myeloid and enterocyte LXA 4 receptors indicated that they are the same seven transmembrane spanning Lipoxin bioactivities. Lipoxins attenuate many of the pro-inflammatory effects of leukotrienes and other G-protein-coupled receptor, and homologous to members of the chemokine superfamily [69, 76, 90] [76 ] . evoked by other eicosanoids [4, [69] [70] 81] . This profile includes GTP hydrolysis, activation of phospholipases Potential therapeutic implications for renal disease A 2 , C and D, arachidonic acid release without oxygenation, and generation of phosphatidic acid [4, [69] [70] 81] . Given that impressive quantities of leukotrienes and lipoxins are generated during inflammation and hyperThe more downstream signal transduction events remain to be defined. Intriguingly, LXA 4 receptor sensitivity reactions, the potential for therapeutic gain by pharmacological manipulation of the leukotriene/ expression is induced in enterocytes by interleukin-13, another mediator proposed to down-regulate inflam-lipoxin network is manifest [1] [2] [3] [4] [5] [6] 22] . Whereas most investigators have focused their efforts on blockade of matory responses [76 ] . LXB 4 also exhibits high affinity binding to several cell types. Stereospecific, spatial and leukotriene biosynthesis and receptor engagement, recent advances in lipoxin biology raise the possibility functional considerations suggest that the LXB 4 receptor is structurally different from the LXA 4 receptor; that this putative endogenous anti-inflammatory eicosanoid system could be amplified or mimicked for however, the LXB 4 receptor has yet to be cloned and characterized [4] . Neither LXA 4 nor LXB 4 compete therapeutic gain. With regard to abrogation of leukotriene synthesis with LTB 4 for binding at the myeloid LTB 4 receptor, suggesting that lipoxins modulate LTB 4 -triggered neu-and bioactivity, prior exposure of rats to pharmacologic inhibitors of 5-lipoxygenase activity ameliorates trophil trafficking at a post-receptor level [4, 69, 70] . LXA 4 may exert partial agonist activity at peptidoleu-the fall in GFR and reduces proteinuria during experimental immune complex glomerulonephritis in rats kotriene receptors on mesangial and smooth muscle cells [4, 18] . It remains to be determined if the ability [83, 84] . In addition, treatment of rats with the FLAP inhibitor MK886 during the heterologous phase of of lipoxins to block leukotriene-stimulated contraction of these cell types hinges on competition at a common nephrotoxic serum nephritis in rats virtually abolishes proteinuria during the subsequent autologous phase receptor or post-receptor signalling events triggered by distinct lipoxin receptors.
[85], presumably by attenuating neutrophil-mediated injury to the glomerular filtration barrier triggered by LTB 4 . Dietary deficiency of essential fatty acids ( EFA) Leukotriene/lipoxin homeostasis: potential molecular has salutary effects on the heterologous phase of switches that shift the balance towards an 'antinephrotoxic serum nephritis [86, 87] . EFA deficient inflammatory' phenotype animals suffer less oliguria, azotemia, sodium retention, neutrophil infiltration of glomeruli, and proteinuria If lipoxins serve as endogenous inhibitors of leukotrienes and promote resolution of inflammation, it is than control animals [86, 87] . EFA deficiency is also associated with impaired intraglomerular LTB 4 biosynlikely that 'molecular switches' are thrown that enhance lipoxin levels or bioactivity, relative to leukotrienes, as thesis, thereby providing a potential explanation for its renoprotective effects. LTD 4 receptor antagonists, inflammatory responses evolve [2] [3] [4] 21, 22] . These switches would shift the balance from a leukotriene-in contrast to 5-lipoxygenase inhibitors, do not prevent leukocyte infiltration of the glomerular tuft, but markdominated 'pro-inflammatory' phenotype to a lipoxindominated 'anti-inflammatory phenotype'. Several edly attenuate the fall in K f and GFR that typifies PHN and nephrotoxic serum nephritis [88] . factors have been identified that may serve this purpose within an inflammatory microenvironment.
More recently, synthetic analogs of LXA 4 and LXB 4 have been designed and synthesized that are resistant As highlighted above, both leukotrienes and lipoxins are generated in abundance by transcellular routes to enzymatic degradation in vitro [80] . These compounds have proved useful tools for probing lipoxin during neutrophil-platelet interactions. Exposure of neutrophil-platelet co-incubations to granulocyte-biology further and for exploring the therapeutic potential of lipoxin pathways [89] [90] [91] . Initial studies macrophage colony-stimulating factor and plateletderived growth factor shifts arachidonate metabolism indicate that some stable analogues of LXA 4 (e.g. 16-phenoxy-LXA 4 ) and LXB 4 (e.g. 5(S)-methyltowards a lipoxin phenotype [47, 51] . Changes in cellular redox potential that lower glutathione levels (neces-LXB 4 ) retain the ability to inhibit neutrophilendothelial cell and neutrophil-epithelial cell adhesion sary for LTC 4 synthesis) have a similar effect suggesting a modulatory role for local hypoxia and oxidant injury in vitro, and attenuate neutrophil recruitment and vascular permeability changes induced by topical [47] [48] [49] . Disruption of platelet cell membranes, as occurs with time following platelet adhesion, also application of LTB 4 to mouse ear [89] [90] [91] . It will be intriguing to determine if these lipoxin mimetics also boosts lipoxin biosynthesis [48] . As discussed previously, the Th2-derived cytokines interleukin-4 and -13 blunt neutrophil recruitment and cytotoxicity in more complex multi-mediator settings, such as glomeruloinduce 15-lipoxygenase activity in a variety of cell types, including glomerular endothelial and epithelial nephritis. The future description of the pathways of lipoxin inactivation in vivo may also offer alternative cells [82] , providing the enzymatic potential for enhanced lipoxin production through interaction of strategies for boosting lipoxin levels and testing their anti-inflammatory potential. neutrophils and resident glomerular cells. Finally, cyto-sanoids and the assessment of glomerular inflammation. J Am 
Summary and conclusions
